Advanced search×

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

S Lindstrom, J Ma, D Altshuler, E Giovannucci, E Riboli, D Albanes, N E Allen, S I Berndt, H Boeing, H B Bueno-de-Mesquita, S J Chanock, A M Dunning, H S Feigelson, J M Gaziano, C A Haiman, R B Hayes, B E Henderson, D J Hunter, R Kaaks, L N Kolonel, L Le Marchand, C Martinez, K Overvad, A Siddiq, M Stampfer, P Stattin, D O Stram, M J Thun, D Trichopoulos, R Tumino, J Virtamo, S J Weinstein, M Yeager, P Kraft, and M L Freedman

J Clin Endocrinol Metab 95(9):E121-7 (2010) PMID 20534771 PMCID PMC2936075

Androgens are key regulators of prostate gland maintenance and prostate cancer growth, and androgen deprivation therapy has been the mainstay of treatment for advanced prostate cancer for many years. A long-standing hypothesis has been that inherited variation in the androgen receptor (AR) gene plays a role in prostate cancer initiation. However, studies to date have been inconclusive and often suffered from small sample sizes.

DOI: 10.1210/jc.2009-1911
Version: za2963e q8za8 q8zb8 q8zcc q8zdf q8zea q8zf7 q8zg1
View PDF

Similar articles you may find interesting…

  1. Serum androgens and prostate cancer.
    A M Nomura, G N Stemmermann, ... F Z Stanczyk

    Cancer Epidemiol Biomarkers Prev 5(8):621-5 (1996) PMID 8824364

    We conducted a nested case-control study in a cohort of 6860 Japanese-American men examined from 1971 to 1975. At the time of examination, a single blood specimen was obtained, and the serum was frozen. After a surveillance period of more than 20 years, 141 tissue-confirmed incident cases of prostat...
  2. Integrating epidemiology and genetic association: the challenge of gene-environment interaction.
    Peter Kraft and David Hunter

    Philos Trans R Soc Lond B Biol Sci 360(1460):1609-16 (2005) PMID 16096111 PMCID 1569522

    We illustrate these ideas with several examples and discuss design and analysis challenges, particularly for studies of gene-environment interaction. We argue that to increase the power to detect interaction effects and limit the number of false positive results, large sample sizes will be needed, w...
  3. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
    Pär P Stattin, Sonja S Lumme, ... Matti M Hakama

    Int J Cancer 108(3):418-24 (2004) PMID 14648709

    We investigated the association of serum levels of testosterone, the principal androgen in circulation, and sex hormone-binding globulin (SHBG) with risk in a case-control study nested in cohorts in Finland, Norway and Sweden of 708 men who were diagnosed with prostate cancer after blood collection...